Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr-Jun;14(2):101-109.
doi: 10.14797/mdcj-14-2-101.

How New Support Devices Change Critical Care Delivery

Affiliations
Review

How New Support Devices Change Critical Care Delivery

Asma Zainab et al. Methodist Debakey Cardiovasc J. 2018 Apr-Jun.

Abstract

Mechanical support devices are used to support failing cardiac, respiratory, or both systems. Since Gibbon developed the cardiopulmonary bypass in 1953, collaborative efforts by medical centers, bioengineers, industry, and the National Institutes of Health have led to development of mechanical devices to support heart, lung, or both. These devices are used as a temporary or long-term measures for acute collapse of circulatory system and/or respiratory failure. Patients are managed on these support devices as a bridge to recovery, bridge to long term devices, or bridge to transplant. The progress in development of these devices has improved mortality and quality of life in select groups of patients. Care of these patients requires a multidisciplinary team approach, which includes cardiac surgeons, critical care physicians, cardiologists, pulmonologists, nursing staff, and perfusionists. Using a team approach improves outcomes in these patients.

Keywords: critical care management; mechanical circulatory support devices; role of multidisciplinary team.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: The authors have completed and submitted the Methodist DeBakey Cardiovascular Journal Conflict of Interest Statement and none were reported.

Figures

Figure 1.
Figure 1.
TandemHeart (CardiacAssist, Inc.) percutaneous placed short-term left ventricular assist device. Reprinted with permission.
Figure 2.
Figure 2.
(A) Effect of Impella® on cardiac output. (B) Position of Impella® inside the left ventricle. © 2018 Abiomed, Inc.
Figure 3.
Figure 3.
The SynCardia Total Artificial Heart is used in end-stage biventricular heart failure and is approved by the FDA as a bridge to heart transplantation. Courtesy of syncardia.com
Figure 4.
Figure 4.
The NuPulse cardiovascular intravascular assist system provides long-term hemodynamic support in advanced heart failure and is intended for use as a bridge to transplant or bridge to recovery. Reprinted with permission.
Figure 5.
Figure 5.
Mechanical circulatory devices are best implanted by hospitals with multidisciplinary teams and specialized units experienced in caring for this exceedingly complex and critical patient population.
Figure 6.
Figure 6.
Ethics teams must uphold and ensure the patient's right to decision making, beneficence of care provided, the physician's responsibility to do no harm, and fair use of resources.

Similar articles

References

    1. The artificial heart program: current status and history. Institute of Medicine (US) Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute. : Hogness JR, VanAntwerp M, . The artificial heart: prototypes, policies, and patients. Washington, DC: National Academies Press (US); 1991. - PubMed
    1. Thiele H, Jobs A, Ouweneel DM, . et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J. 2017. December 14; 38 47: 3523– 31. - PubMed
    1. Maini B. Letter by Maini regarding article, “percutaneous left-ventricular support with the impella-2.5-assist device in acute cardiogenic shock: results of the impella-EUROSHOCK-registry”. Circ Heart Fail. 2013. July; 6 4: e55. - PubMed
    1. Friedman PA, Munger TM, Torres N, Rihal C.. Percutaneous endocardial and epicardial ablation of hypotensive ventricular tachycardia with percutaneous left ventricular assist in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 2007. January; 18 1: 106– 9. - PubMed
    1. Port SC, Patel S, Schmidt DH.. Effects of intraaortic balloon counterpulsation on myocardial blood flow in patients with severe coronary artery disease. J Am Coll Cardiol. 1984. June; 3 6: 1367– 74. - PubMed

MeSH terms